#BACRDevCM

The British Association for Cancer Research's (BACR) Conference on Development of Cancer Medicines The use of preclinical and clinical information to inform patient selection for novel cancer therapies is key, with the development and use of models to interrogate target dependencies based on molecular pathology being well-established. Recent studies also suggest that it may be... Continue Reading →